HomeNewsBusinessCoronavirus impact: Permanent WFH could be the CFO's new friend in post COVID-19 world

Coronavirus impact: Permanent WFH could be the CFO's new friend in post COVID-19 world

Driven to unusual cost cutting measures, finance heads are looking rather benignly at remote work options, according to a recent Gartner survey.

April 09, 2020 / 09:38 IST
Story continues below Advertisement

The demand and supply shocks due to the COVID-19 pandemic reverberating through the world need unusual counter-measures from businesses.

And a greater proportion of their workforce working remotely is an attractive option for CFOs, found a recent survey by the research and advisory group, Gartner.

Story continues below Advertisement

The survey of "317 CFOs and finance leaders on March 30, 2020 revealed that 74% of them will move at least 5% of their previously on-site workforce to permanently remote positions post-COVID 19," it found.

Click to follow the latest on Coronavirus in our dedicated LIVE blog

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show